Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Here are two other Bio-Tech that we may use to value BPTH. They both have more cash in the Bank and are more robust, better run companies but neither have a drug approved.

ARWR with a cap of 500 million

ABUS with a cap of 320 million

If BPTH was valued at 400 million with 20 million shares outstanding the PPS would be $20. I think we would all be satisfied with that market cap.